Terbinafine topical - Moberg Pharma

Drug Profile

Terbinafine topical - Moberg Pharma

Alternative Names: MOB-015; MOB015B

Latest Information Update: 06 Feb 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Moberg Derma
  • Developer Moberg Pharma
  • Class Antifungals; Naphthalenes; Small molecules
  • Mechanism of Action Cell membrane modulators; Squalene monooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Onychomycosis

Highest Development Phases

  • Phase III Onychomycosis

Most Recent Events

  • 16 Dec 2017 Moberg Pharma AB initiates enrolment in a phase I trial for Onychomycosis (In adolescents, In adults, In the elderly) in USA (Topical) (NCT03244280)
  • 01 Aug 2017 Moberg Pharma AB plans a phase I trial for Onychomycosis (In adolescents, In adults, In the elderly) (Topical) (NCT03244280)
  • 01 Sep 2016 Phase-III clinical trials in Onychomycosis (In adolescents, In adults, In the elderly) in USA, Canada and Germany (Topical) (NCT02859519,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top